Asthalin 4 mg

Product Overview

Asthalin 4 mg contains salbutamol sulphate, a short-acting beta-2 adrenergic agonist (SABA) used as a bronchodilator. Manufactured by Cipla, it is available in tablet form with a strength of 4 mg and supplied in packs of 180 tablets.

Salbutamol is widely used in the management of reversible airway obstruction and is considered a first-line rescue medication in asthma and related respiratory conditions.

Drug Class

Asthalin belongs to the short-acting beta-2 agonist (SABA) class. These agents rapidly relax bronchial smooth muscle, leading to bronchodilation and improved airflow.

Indications

Clinical Use

• Asthma (acute relief and prevention of bronchospasm)
• Chronic obstructive pulmonary disease (COPD)
• Exercise-induced bronchospasm

Therapeutic Role

Salbutamol tablets are typically used when inhalation therapy is not feasible or as an adjunct to inhaled bronchodilators.

Mechanism of Action

Salbutamol selectively stimulates beta-2 adrenergic receptors in bronchial smooth muscle, resulting in:

• Relaxation of airway muscles
• Bronchodilation
• Improved airflow and oxygenation

It has a rapid onset of action, usually within minutes, although oral forms may have a slightly delayed onset compared to inhaled formulations.

Dosage & Administration

• Adults: 2–4 mg, 3–4 times daily
• Maximum dose: Typically up to 32 mg/day (divided doses)

Asthalin 4 mg tablets are usually taken multiple times per day depending on symptom severity and physician guidance.

Use in Females

Asthalin is commonly used in females and is generally well tolerated. Considerations include:

• Safe when used as prescribed
• Use during pregnancy only if clearly needed

Pre-Treatment Assessment

Before initiating therapy:

• Evaluate respiratory condition severity
• Assess cardiovascular history (e.g., arrhythmias)
• Review concurrent medications

Comparative Analysis

Salbutamol vs Other SABAs

• Rapid onset of bronchodilation
• Widely available and well studied
• Short duration of action (4–6 hours)

Oral vs Inhaled Salbutamol

• Oral tablets have slower onset
• Higher systemic side effects compared to inhaled forms
• Useful when inhalers are not suitable

Risk Management

Common Side Effects

• Tremors
• Palpitations
• Headache
• Nervousness

Serious Side Effects

• Cardiac arrhythmias
• Hypokalemia (low potassium levels)
• Severe tachycardia

Systemic side effects are more pronounced with oral administration compared to inhaled forms.

Mitigation Strategies

• Use lowest effective dose
• Monitor heart rate and symptoms
• Avoid overuse

Drug Interactions

• Beta-blockers: may reduce efficacy
• Diuretics: increase risk of hypokalemia
• Other sympathomimetics: additive effects

Sourcing & Selection

When selecting salbutamol products, consider:

• Trusted manufacturers such as Cipla
• Proper labeling and dosage accuracy
• Storage conditions to maintain stability

Conclusion

Asthalin 4 mg (salbutamol) is an effective oral bronchodilator for managing bronchospasm in asthma and COPD. While inhaled forms are generally preferred, oral tablets provide an alternative when needed, with careful monitoring for systemic side effects.